What is the scope and value of Johnson & Johnson's newly announced talc litigation settlement?

Johnson & Johnson announced a $5.5 billion settlement to resolve approximately 69,000 talc-related lawsuits consolidated in federal court, along with related state court cases, representing 99.75% of the remaining talc claims; the company has consistently denied that its talc products cause cancer, asserting talc was safe and asbestos-free, and discontinued U.S. sales of talc-based baby powder in 2020 in favor of a cornstarch alternative.

Why did Johnson & Johnson pursue this settlement now, after a recent legal victory?

The settlement follows a significant federal court ruling just last week in which a judge cast doubt on plaintiffs’ ability to prove that talc specifically caused their ovarian cancer — a key evidentiary hurdle — yet J&J opted to settle amid the resumption of litigation in March 2025 after more than three years of stays linked to its unsuccessful attempts to resolve the claims via a bankruptcy filing by a shell company.

Johnson & Johnson announces $5.5 billion settlement of talc lawsuits

Jul 27, 2026

Johnson & Johnson agreed to a $5.5 billion settlement resolving nearly 70,000 lawsuits alleging its talc products caused ovarian cancer. The company denies the claims and switched to cornstarch-based baby powder in the U.S. in 2020.

reuters

Johnson & Johnson to Pay $5.5 Billion Settlement in Talc Cancer Lawsuit

theguardian

2026-07-27

Johnson & Johnson announces $5.5 billion settlement of talc lawsuits

Johnson & Johnson announces $5.5 billion settlement of talc lawsuits

FAQ